Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27


Risk of ESKD in Older Live Kidney Donors with Hypertension.

Al Ammary F, Luo X, Muzaale AD, Massie AB, Crews DC, Waldram MM, Qadi MA, Garonzik-Wang J, Henderson ML, Brennan DC, Wiseman AC, Lindrooth RC, Snyder JJ, Coresh J, Segev DL.

Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1048-1055. doi: 10.2215/CJN.14031118. Epub 2019 Jun 25.


The changing landscape of live kidney donation in the United States from 2005 to 2017.

Al Ammary F, Bowring MG, Massie AB, Yu S, Waldram MM, Garonzik-Wang J, Thomas AG, Holscher CM, Qadi MA, Henderson ML, Wiseman AC, Gralla J, Brennan DC, Segev DL, Muzaale AD.

Am J Transplant. 2019 Sep;19(9):2614-2621. doi: 10.1111/ajt.15368. Epub 2019 May 3.


The landscape of international living kidney donation in the United States.

Al Ammary F, Thomas AG, Massie AB, Muzaale AD, Shaffer AA, Koons B, Qadi MA, Crews DC, Garonzik-Wang J, Fang H, Brennan DC, Lentine KL, Segev DL, Henderson ML.

Am J Transplant. 2019 Jul;19(7):2009-2019. doi: 10.1111/ajt.15256. Epub 2019 Feb 8.


Assessing the Attitudes and Perceptions Regarding the Use of Mobile Health Technologies for Living Kidney Donor Follow-Up: Survey Study.

Eno AK, Thomas AG, Ruck JM, Van Pilsum Rasmussen SE, Halpern SE, Waldram MM, Muzaale AD, Purnell TS, Massie AB, Garonzik Wang JM, Lentine KL, Segev DL, Henderson ML.

JMIR Mhealth Uhealth. 2018 Oct 9;6(10):e11192. doi: 10.2196/11192.


Early Hypertension and Diabetes After Living Kidney Donation: A National Cohort Study.

Holscher CM, Bae S, Thomas AG, Henderson ML, Haugen CE, DiBrito SR, Muzaale AD, Garonzik Wang JM, Massie AB, Lentine KL, Segev DL.

Transplantation. 2019 Jun;103(6):1216-1223. doi: 10.1097/TP.0000000000002411.


Lower Mortality in Living Kidney Donors With ESRD Versus Matched Nondonors With ESRD.

Muzaale AD.

Kidney Int Rep. 2018 Jul 7;3(5):1023-1024. doi: 10.1016/j.ekir.2018.07.002. eCollection 2018 Sep. No abstract available.


Living donor postnephrectomy kidney function and recipient graft loss: A dose-response relationship.

Holscher CM, Ishaque T, Garonzik Wang JM, Haugen CE, DiBrito SR, Jackson KR, Muzaale AD, Massie AB, Al Ammary F, Ottman SE, Henderson ML, Segev DL.

Am J Transplant. 2018 Nov;18(11):2804-2810. doi: 10.1111/ajt.15061. Epub 2018 Aug 31.


Racial differences in completion of the living kidney donor evaluation process.

Kumar K, Tonascia JM, Muzaale AD, Purnell TS, Ottmann SE, Al Ammary F, Bowring MG, Poon A, King EA, Massie AB, Chow EKH, Thomas AG, Ying H, Borja M, Konel JM, Henderson M, Cameron AM, Garonzik-Wang JM, Segev DL.

Clin Transplant. 2018 Jul;32(7):e13291. doi: 10.1111/ctr.13291. Epub 2018 Jun 15.


Databases for surgical health services research: National Health and Nutrition Examination Survey.

Muzaale AD.

Surgery. 2019 May;165(5):873-875. doi: 10.1016/j.surg.2018.02.006. Epub 2018 Apr 27. No abstract available.


Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors.

Muzaale AD, Althoff KN, Sperati CJ, Abraham AG, Kucirka LM, Massie AB, Kitahata MM, Horberg MA, Justice AC, Fischer MJ, Silverberg MJ, Butt AA, Boswell SL, Rachlis AR, Mayor AM, Gill MJ, Eron JJ, Napravnik S, Drozd DR, Martin JN, Bosch RJ, Durand CM, Locke JE, Moore RD, Lucas GM, Segev DL.

Am J Transplant. 2017 Jul;17(7):1823-1832. doi: 10.1111/ajt.14235. Epub 2017 May 12.


Quantifying Postdonation Risk of ESRD in Living Kidney Donors.

Massie AB, Muzaale AD, Luo X, Chow EKH, Locke JE, Nguyen AQ, Henderson ML, Snyder JJ, Segev DL.

J Am Soc Nephrol. 2017 Sep;28(9):2749-2755. doi: 10.1681/ASN.2016101084. Epub 2017 Apr 27.


Concerns about the long-term safety of live kidney donors are justified.

Muzaale AD, Massie AB, Segev DL.

Eur J Epidemiol. 2017 Feb;32(2):91-93. doi: 10.1007/s10654-017-0241-3. Epub 2017 Mar 24. No abstract available.


Frailty and Cause-Specific Hospitalization Among Persons Aging With HIV Infection and Injection Drug Use.

Piggott DA, Muzaale AD, Varadhan R, Mehta SH, Westergaard RP, Brown TT, Patel KV, Walston JD, Leng SX, Kirk GD.

J Gerontol A Biol Sci Med Sci. 2017 Mar 1;72(3):389-394. doi: 10.1093/gerona/glw142.


A Smartphone App for Increasing Live Organ Donation.

Kumar K, King EA, Muzaale AD, Konel JM, Bramstedt KA, Massie AB, Segev DL, Cameron AM.

Am J Transplant. 2016 Dec;16(12):3548-3553. doi: 10.1111/ajt.13961. Epub 2016 Aug 10.


Patterns of End-Stage Renal Disease Caused by Diabetes, Hypertension, and Glomerulonephritis in Live Kidney Donors.

Anjum S, Muzaale AD, Massie AB, Bae S, Luo X, Grams ME, Lentine KL, Garg AX, Segev DL.

Am J Transplant. 2016 Dec;16(12):3540-3547. doi: 10.1111/ajt.13917. Epub 2016 Jul 12.


Recipient Outcomes Following Transplantation of Allografts From Live Kidney Donors Who Subsequently Developed End-Stage Renal Disease.

Muzaale AD, Massie AB, Anjum S, Liao C, Garg AX, Lentine KL, Segev DL.

Am J Transplant. 2016 Dec;16(12):3532-3539. doi: 10.1111/ajt.13869. Epub 2016 Jun 27.


Long-term Renal Function in Living Kidney Donors Who Had Histological Abnormalities at Donation.

Fahmy LM, Massie AB, Muzaale AD, Bagnasco SM, Orandi BJ, Alejo JL, Boyarsky BJ, Anjum SK, Montgomery RA, Dagher NN, Segev DL.

Transplantation. 2016 Jun;100(6):1294-8. doi: 10.1097/TP.0000000000001236.


Outcomes of Live Kidney Donors Who Develop End-Stage Renal Disease.

Muzaale AD, Massie AB, Kucirka LM, Luo X, Kumar K, Brown RS, Anjum S, Montgomery RA, Lentine KL, Segev DL.

Transplantation. 2016 Jun;100(6):1306-12. doi: 10.1097/TP.0000000000000920.


Outcomes after kidney donation.

Massie AB, Muzaale AD, Segev DL.

JAMA. 2014 Jul 2;312(1):94-5. doi: 10.1001/jama.2014.6120. No abstract available.


Kidney donation and risk of ESRD--reply.

Muzaale AD, Massie AB, Segev DL.

JAMA. 2014 Jul 2;312(1):93-4. doi: 10.1001/jama.2014.5524. No abstract available.


Experiences obtaining insurance after live kidney donation.

Boyarsky BJ, Massie AB, Alejo JL, Van Arendonk KJ, Wildonger S, Garonzik-Wang JM, Montgomery RA, Deshpande NA, Muzaale AD, Segev DL.

Am J Transplant. 2014 Sep;14(9):2168-72. doi: 10.1111/ajt.12819. Epub 2014 Jul 16.


Risk of end-stage renal disease following live kidney donation.

Muzaale AD, Massie AB, Wang MC, Montgomery RA, McBride MA, Wainright JL, Segev DL.

JAMA. 2014 Feb 12;311(6):579-86. doi: 10.1001/jama.2013.285141.


Identifying appropriate recipients for CDC infectious risk donor kidneys.

Chow EK, Massie AB, Muzaale AD, Singer AL, Kucirka LM, Montgomery RA, Lehmann HP, Segev DL.

Am J Transplant. 2013 May;13(5):1227-34. doi: 10.1111/ajt.12206.


Frailty, HIV infection, and mortality in an aging cohort of injection drug users.

Piggott DA, Muzaale AD, Mehta SH, Brown TT, Patel KV, Leng SX, Kirk GD.

PLoS One. 2013;8(1):e54910. doi: 10.1371/journal.pone.0054910. Epub 2013 Jan 31.


Estimates of early death, acute liver failure, and long-term mortality among live liver donors.

Muzaale AD, Dagher NN, Montgomery RA, Taranto SE, McBride MA, Segev DL.

Gastroenterology. 2012 Feb;142(2):273-80. doi: 10.1053/j.gastro.2011.11.015. Epub 2011 Nov 19.


Living kidney donors ages 70 and older: recipient and donor outcomes.

Berger JC, Muzaale AD, James N, Hoque M, Wang JM, Montgomery RA, Massie AB, Hall EC, Segev DL.

Clin J Am Soc Nephrol. 2011 Dec;6(12):2887-93. doi: 10.2215/CJN.04160511. Epub 2011 Oct 27.


Perioperative mortality and long-term survival following live kidney donation.

Segev DL, Muzaale AD, Caffo BS, Mehta SH, Singer AL, Taranto SE, McBride MA, Montgomery RA.

JAMA. 2010 Mar 10;303(10):959-66. doi: 10.1001/jama.2010.237.


Supplemental Content

Loading ...
Support Center